
89Bio Investor Relations Material
Latest events

Status Update
89Bio
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from 89Bio Inc
Access all reports
89Bio Inc is a clinical-stage biopharmaceutical company focused to the development and commercialization of therapies aimed at treating liver and cardio-metabolic diseases. The company is building a pipeline that includes biologic and small molecule treatments, focusing on addressing unmet medical needs in these therapeutic areas. The company is headquartered in San Francisco, California, and its shares are listed on the NASDAQ under the symbol ETNB.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ETNB
Country
🇺🇸 United States